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Breast cancer recurrenceAbstract Objective: To assess role of Diffusion weighted imaging (DWI) in addition to dynamic
contrast-enhanced magnetic resonance mammography (DCE-MRM) in detection of breast cancer
recurrence after surgery.
Patients and methods: Sixty female patients who underwent breast surgery were included in this
prospective study. Patients were examined by sonomammography followed by DCE-MRI to
exclude recurrence. DWI was performed using b values of 0, 50, and 850 s/mm2. Patients with sus-
pected recurrence were subjected to histopathological confirmation.
Results: Twenty seven patients had pathologically proven recurrence and thirty three patients
showed spectrum of post operative changes. DCE-MRI was superior to DWI with 2 false positive
(FP) cases and no false negative (FN) cases, while DWI showed 3 (FN) cases and 4 (FP) cases.
DCE-MRI & DWI showed sensitivity (100%, 88.9%), specificity (93.9%, 87.9%), positive predic-
tive value (PPV) (93.1%, 88.9%), negative predictive value (NPV) (100%, 90.6%) & accuracy
(96.7%, 88.3%) respectively.
Conclusion: Our study showed better diagnostic performance for DCE-MRI compared to DWI in
post operative breast assessment. However, DWI can provide an alternative diagnostic tool to con-
trast administration ‘‘if interpreted in association with conventional MR sequences” thus can be
used when contrast media is contraindicated.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Breast cancer is the most frequent cancer in women, where it
accounts for 27% of all female cancers. It is considered to be
the second after lung cancer as the most prevalent cause of
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Fig. 1 Receiver operating characteristic (ROC) curve of ADC
value in the studied group.
1152 S.I.S. El-nasr et al.death due to cancer in women (1). After surgical treatment of
breast cancer and radiation, the incidence of local recurrence is
between 1% and 2% per year, with most of the recurrences
occurring in the first 5 years (2).
Early detection and proper treatment of recurrent disease is
of high importance as it still may present without distant
metastases. Also, second ipsilateral primary carcinomas in
the treated breast can occur at every site and develop on aver-
age 7 years after the first primary tumor (3).
For many years, magnetic resonance imaging (MRI) exam-
ination has been widely accepted as a diagnostic tool for eval-
uation of breast cancer (4). One of its indications, is the
differential diagnosis between cancer recurrence and surgical
scar in surgically treated patients (5). Both breast surgeries
and radiotherapy can produce scarring with architectural dis-
tortion. Thus differentiating those expected post operative
and related treatment changes from true recurrence on physi-
cal examination as well as on post-treatment breast imaging
can be sometimes challenging (6).
Over the past decade, many new MR techniques and inter-
pretation strategies have been developed aiming to improve the
specificity and positive predictive value (PPV) of breast MRI.
Of these diffusion weighted imaging (DWI) (7) is an unen-
hanced MRI sequence that measures the random motion of
free water protons (Brownian motion) and characterizes differ-
ent tissue properties, and thus can provide complementary0
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Fig. 2 Shown is the diagnostic perfinformation to dynamic contrast enhanced MRI (DCE-MRI)
(8,9).2. Patients and methods
2.1. Patients
Our study was a prospective one, approved by the Faculty of
Medicine Ethics committee of the Cairo University; cases had
given informed consents for their used data. The study was
performed at least 6 months after the operation on sixty breast
cancer female patients who underwent CBS (n= 29) or MRM
(n= 31) where two of them had reconstructive surgery. The
study was conducted at radiology department of Kasr El Aini
hospital and National Cancer institute – Cairo University in
the period from March 2013 until March 2015. The patients
underwent full history taking and clinical examination. Digital
mammography, US and MRI examinations were performed
for all patients.
Patient preparation: Renal laboratory function tests were
done for all patients before contrast enhanced MRI. An I.V.
cannula was inserted in the patients’ contralateral arm to the
side of breast surgery whenever possible. After lying in prone
position with a dedicated bilateral breast coil, Magnevist
(gadopentetate dimeglumine) was injected as 0.2 mL/kg
(0.1 mmol/kg) intravenously by power injector.
2.2. Methods
MR imaging was performed for all cases with high field
strength 1.5 T (Gyroscan Intera Phillips, medical system
Netherland) with the following protocol:
 Precontrast sequences: T1 weighted fast spin echo sequence
(TR = 500 ms, TE = 5.3 ms) in axial orientation with slice
thickness = 4 mm, matrix = 512  192, flip angle = 90
and FOV= 34–37 cm. T2 weighted fast spin echo sequence
(TR = 120 ms, TE = 4.9 ms) in axial & sagittal orientation
with slice thickness = 4 mm, matrix = 512  192, flip
angle = 90 and FOV= 34–37 cm. T2-weighted inversion
recovery (IR) (TR = 80, TE = 6.5 ms) in axial orientation
with slice thickness = 4 mm, matrix = 512  192, flip
angle = 90 and FOV= 34–37 cm.PPV NPV Efficacy
3.1 100 96.7
88.9 90.6 88.3
mic DW
ormance for DCE-MRI & DWI.
Role of diffusion weighted imaging and MR mammography 1153 STIR sequence: TR= 80, TE = 6.5 ms) in axial orienta-
tion with slice thickness = 4 mm, matrix = 512  192, flip
angle = 90 and FOV= 34–37 cm.
 DW sequences in axial orientation with TR = 5000,
TE = 77 ms, slice thickness = 5 mm, 1 mm interslice gap,
matrix = 124  100 and b-values (0, 50 and 850 s/mm2).
 Dynamic post contrast series were performed using six
series of 3D ‘T1 High Resolution Isotropic Volumetric
Examination’ THRIVE acquisition. One sequence before
& five after contrast injection (nearly at 1.5, 3, 4.5, 6 and
7.5 min) with parameters TR = 2.8, TE = 9 ms and slice
thickness = 1.5 mm.
 Rate of injection was 10 mL per 15 s followed by saline
flush.
Image interpretation; Data analysis and interpretation were
performed by two experienced radiologists as follows:
Interpretation of dynamic contrast MRI: Subtraction images
were first examined followed by examination of the rest of the
sequences. Cases that showed pathological enhancement
‘masses/non mass enhancement’ were analyzed concerning
the following: side of the lesion, whether on the ipsilateral or
contralateral side of the previous surgery, number of lesions
(multifocal or multicentric), size, morphology of the lesion
‘‘shape and margin”, patterns of enhancement, kinetic analysis
with drawing of region of interest (ROI) on the lesion and
performing the corresponding time intensity curves with(a) (b)
(c) (d
Fig. 3 Female patient 36 year old underwent right CBS 2 years ago:
operative bed (red arrow), (b) time-signal intensity curve shows delayed
DWI & (d) ADC map with ROI at the operative bed (red circle) sh
Findings are consistent with post operative sequel (post operative scarcalculating maximum relative enhancement and time to peak.
Associated findings as edema, skin thickening and nipple
retraction were also reported. DCE-MRI was considered
positive in cases that showed suspicious enhancement and
patients were further sent for pathological confirmation.
MRI was considered negative in the absence of suspicious
enhancement and patients were sent for follow-up (3–
6 months). Suspicious enhancement includes heterogeneous,
ring or non mass enhancement of the lesion.
Interpretation of DWI: DWI is assessed both qualitatively
and quantitatively in all patients.
Qualitatively: By the visualization of signal intensity that
corresponds to the lesion of concern in the conventional
images and observing its signal character with increasing b
values and in the corresponding Apparent Diffusion Coeffi-
cient (ADC) maps. The ADC map for each lesion was
calculated using the different b values (0, 50 and 850 s/mm2).
In order to avoid contamination by adjacent structures, an
oval region of interest (ROI) was chosen with average diameter
of 4–6 mm and drawn over the lesion with exclusion of areas of
breaking down whenever possible.
Quantitatively: By measuring ADC values on ADC maps
for the positive cases at the site of suspected recurrence and
for the negative cases at the site of the post operative changes.
We considered 1.24  103 mm2/s to be our cutoff ADC
value in differentiating benign from malignant breast lesions
according to Pereira et al. (10).) 
(a) MR subtraction sequence shows stippled enhancement at the
peak of contrast uptake with continuous rising (type I) curve, (c)
owed facilitated diffusion with ADC value of 1.4  103 mm2/s.
) with no recurrence.
1154 S.I.S. El-nasr et al.DWI positive lesions showed abnormal bright signal inten-
sity ‘restriction’ that remains enhanced with increasing b values
and showed intermediate/low signal intensity on the corre-
sponding ADC map with ADC values lower than or equal
to our cutoff point.
We did not perform FNA in our study and pathological
confirmation was obtained using tissue core biopsy.
Statistical analysis: We used software SPSS computer pro-
gram (version 16 windows) for data analysis.
3. Results
Sixty female patients were included in our final statistical
analysis. The patients’ mean age was 49.3 ± 9.95 (range from
35–68 y). Twenty-nine patients underwent Conservative
Breast Surgery (CBS) and 31 underwent MRM, 2 of them
had reconstructive surgery ‘‘Transverse Rectus Abdominis(a) (
(c)
(e)
Fig. 4 Female patient 65 year old underwent right MRM 1.5 years a
bed with low signal capsule, (b) subtraction sequence shows margina
delayed peak of contrast uptake with rising curve (type I), (d) DWI sho
and after drawing ROI, the ADC value was 1.34  103 mm2/s. DiagMyocutaneous” (TRAM). Pathology was done for 32 cases:
27 were pathologically confirmed to have recurrence while
recurrence was excluded in the remaining 5 cases. The rest of
cases (n= 28) showed spectrum of post-operative changes
and were considered negative for malignancy by imaging and
no newly developed lesions on follow-up.
Recurrent lesions were detected in the positive group (27
cases) in a period of 9–60 months (mean 28 months) after oper-
ation. Twelve cases showed recurrence at the operative bed
(ipsilateral recurrence). Eleven cases showed recurrence/newly
developed malignant lesions on the contralateral side. Three
cases had bilateral malignancy while one case showed metasta-
sis in the chest wall (new lesion centered on the manubrium
sterni).
Dynamic sequence in our study showed pathological
enhancement in 29 cases (48.3%). They showed early peak of
contrast uptake (in first two minutes) with high maximumb) 
(d)
go: (a) T2WI shows high signal oval shaped cavity at the operative
l enhancement of the cavity, (c) time-signal intensity curve shows
ws faint marginal high signal and (e) ADC map shows high signal
nosis was operative bed chronic seroma.
Role of diffusion weighted imaging and MR mammography 1155relative enhancement and either early wash out type III curve
(n= 18) or type II plateau curve (n= 11). Those 29 cases rep-
resent 27 TP cases (pathologically proven) and 2 FP cases (one
case was foreign body granuloma & the other was borderline
phyllodes tumor). The remaining 31 cases (51.7%) showed
no suspicious enhancement and were diagnosed as TN cases
(their follow-up showed no changes).
According to DWI, 28 cases (46.7%) showed high signal
‘restricted diffusion’ on high b value 850 mm2/s and corre-
sponding low/intermediate signal on the ADC maps. Those
28 cases included 24 TP cases and 4 FP cases (2 cases were
fat necrosis and 2 cases were atypical hyperplasia). In the
remaining 32 cases (53.3%), 29 were TN cases (did not show
low signal on the ADC maps), while the remaining 3 cases
were FN cases (two cases with tumoral breaking down showed
high signal on the ADC maps and one case had small lesion
that was not appreciated on the ADC map).
The mean ADC value of the negative group [1.50 ± 0.45
(range = 0.5–2.6  103 mm2/s)] was statistically higher than
the mean ADC value of the positive group (pathologically pro-
ven) [0.81 ± 0.23 (range = 0.3–1.2  103 mm2/s)] with p
value = 0.001 (p< 0.01 = highly significant).
The ROC curve indicated a good statistical performance of
the ADC values to predict the presence of malignant lesions
(area under the curve = 0.941) Fig. 1.
Pathological confirmation was done for thirty-two patients;
‘IDC’ was found in twenty-six (43.3%) patients (Fig. 5), ‘ILC’
in one patient (1.7%) with a total of twenty-seven positive(a) (
(c) (d)
Fig. 5 A female patient, 39 year old, presented with suspicious area
performing breast ultrasound two years after surgery. (a) MR subtrac
retroareolar region. (b) Time signal intensity curve with rapid rise an
intensity. (d) ADC map showing low signal with ADC value of 0.96 patients and five patients showed no recurrence and their
pathology revealed atypical hyperplasia in two cases, border-
line phyllodes tumor in one case, foreign body granuloma in
one case and fat necrosis in one case (Fig. 6). So the latter five
cases as well as the rest of patients [they were twenty-five
patients (41.7%) who had post operative scarring (Fig. 3),
one patient (1.7%) had fat necrosis and two patients (3.3%)
had seromas (Fig. 4) represent the negative cases in our study
(n= 33).
After calculating the sensitivity, specificity, PPV, NPV and
accuracy for dynamic and DWI, dynamic sequence showed
better diagnostic performance than DWI as shown in Fig. 2.
4. Discussion
Breast cancer is a disease that carries a risk of recurrence
whether at the lumpectomy bed, adjacent to its margin or else-
where in the breast (11).
DCE-MRI has been accepted as a highly significant diag-
nostic tool that can aid in detection and characterization of
primary as well as recurrent breast cancers (12)
Having a high sensitivity that sometimes can exceed all
other breast imaging modalities, DCE-MRI showed a some-
how limited specificity, that required searching for additional
techniques aiming to improve its specificity (13).
DWI is an unenhanced MRI sequence that reflects the ran-
dom thermal motion of water molecules. DWI can give an
important information about tissue cellularity thus can be ab)
of distortion retroareolar in location of a previous left CBS upon
tion sequence showing suspicious heterogeneously enhancing left
d rapid wash out (type III curve). (c) DWI showing high signal
103 mm2/s. Pathology revealed IDC.
(a) (b)
(c) (d)
(e) (f)
Fig. 6 Female patient 39 year old underwent right mastectomy 14 months ago. Post operative scar tissue that elicits low signal on (a)
T1WI and high signal on the (b) STIR sequence with central focal area of fat signal intensity. Associated skin thickening, retraction and
edema are also noted. (c) MR subtraction images show marginal enhancement at the operative bed focal area. (d) Time intensity curve
shows continuous rising curve. (e) High signal is seen in DWI with b value (850) and (f) low value on ADC map (0.49  103 mm2/s).
Tissue core biopsy showed focal area of fat necrosis with no malignant cells.
1156 S.I.S. El-nasr et al.useful technique for the discrimination between benign and
malignant breast lesions (2,14).
Our study aimed to evaluate the diagnostic role of DWI in
addition to DCE-MRM in assessing the postoperative patients
and thus to discriminate between true cancer recurrence from
accepted benign post operative sequelae.
The DCE-MRI in our study diagnosed 29 patients as pos-
itive for recurrence compared to 31 negative cases. After
pathological results were obtained for 32 as well as follow-up
images for the rest of cases, all were compared to DCE-MRI
results and revealed 27 patients as TP cases, 31 as TN cases,
2 as FP cases and no FN. As a result DCE-MRI showed
100% sensitivity, 93.9% specificity, 93.1% ‘PPV’, 100%
‘NPV’ and 96.7% accuracy.On the other hand, DWI diagnosed 28 cases positive for
recurrence and 32 negative for recurrence. DWI showed 24
TP cases, 29 TN cases, 4 FP cases and 3 FN cases. The diag-
nostic performance of DWI showed 88.9% sensitivity, 87.9%
specificity, 88.9% ‘PPV’, 90.6% ‘NPV’ and 88.3% accuracy.
As a result our study showed that diagnostic performance
of dynamic sequence was higher than that of the DWI.
Our results disagree with Rinaldi et al. (2) & Mansour and
Behairy (15) results. Both studies showed that DWI was higher
in the specificity than the dynamic MRI. This can possibly be
explained as DWI in our study showed higher number of FP
& FN cases (compared to dynamic sequence) decreasing its
specificity and sensitivity respectively. Also in our study we
compared the results obtained from DWI to that of dynamic
Role of diffusion weighted imaging and MR mammography 1157images, unlikeMansour and Behairy study which combined the
conventional sequences ‘T1WI & T2STIR’ in the diagnoses of
some cases through DWI by raising its diagnostic accuracy.
This was better appreciated in cases of fat necrosis that can give
a FP appearance on dynamic as well as on DWI (as happened
in our study) and thus were diagnosed correctly as TN cases.
In our study, the mean ADC value of benign lesions (1.50
± 0.45 SD) was statistically higher than the mean ADC value
of malignant lesions (0.81 ± 0.23SD), [p value = 0.001]. One
exception in our study is the 2 cases of fat necrosis, as they
showed low ADC values mimicking recurrence (mean ADC
of fat necrosis was 0.695 ± 0.21). Fortunately those two cases
were diagnosed by detection of fat signal in the conventional
sequences; presence of high signal in the lesion in T1WI
showed signal drop in T2 STIR. This result matched Mansour
and Behairy (15) results as their mean ADC value of the
benign lesions (1.2 ± 0.34  103 mm2/s) was statistically
higher than that of the malignant lesions (0.83
± 0.15  103 mm2/s) also with 2 exceptions in cases of fat
necrosis as in our study and in cases of fibrosis. Both have
low values (fibrosis was = 0.77 ± 0.2  103 mm2/s, and fat
necrosis was = 0.56 ± 0.1  103 mm2/s).
Our study also matched Rinaldi and co-authors (2) study,
where the mean ADC value of their local recurrence patients
was 1.25 ± 0.29  103 mm2/s, while the mean ADC value
for benign post operative sequelae was 1.84 ± 0.24 
103 mm2/s. Another study was conducted by Abdulghaffara
and Tag-Aldeinb (16) that concluded that all cases of local
tumor recurrence showed lower ADC values [mean ADC=
(0.95 ± 0.37  103 mm2/s)] than benign post operative
changes [mean ADC= (1.69 ± 0.16  103 mm2/s)] which
also matched our results. However, one exception of the
benign sequelae was a case of hematoma that showed lower
ADC value (0.34–0.56  103 mm2/s) and was diagnosed by
conventional MRI. We did not have any cases of hematomas
in our study to compare with.
Although DWI has the advantage of being an easy,
contrast free imaging sequence, it poses some limitations.
Some of them appeared in our study as in cases of small lesions
(lesions are difficult to elicit on the ADC maps so difficult
to be measured) and in cases of fat necrosis (can give low
ADC values so interpreted as FP lesions). Also fibrosis and
hematomas can give false positive appearance on DWI as
stated by other authors (15,16) respectively.
Based on our study we can recommend patients with suspi-
cious tiny lesions which are difficult to be diagnosed by DWI;
dynamic sequences can be satisfactory for diagnosis. Also in
cases with suspected fat necrosis which is a frequent finding
in the post operative breast, conventional sequences are supe-
rior in detection of fat signal intensity within the lesion to
avoid diagnostic dilemmas caused by interpretation of DWI
or dynamic sequences alone in many cases.
5. Conclusion
Although DWI is a safe, fast, contrast free sequence that can
be easily added to all MRI machines, it can possess some lim-
itations. Based on our study, dynamic sequence showed better
diagnostic performance than DWI in the setting of the post
operative breast assessment. DWI can be however, a goodalternative imaging technique if combined with conventional
MR sequences in patients where contrast media is better
avoided as in renal impairment and during pregnancy.
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